JLJialu Li

Jialu Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jialu Li has a total of 93 co-authors. Here are the top co-authors by number of shared publications:

  • Dong Deng

    Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu, China

    14 shared publications
  • Xiang Wang

    Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu, China

    12 shared publications
  • Li Guo

    Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu, China

    11 shared publications
  • Pengliang Chi

    Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu, China

    9 shared publications
  • Qianqian Qi

    Clinical Laboratory, West China Second University Hospital, Sichuan University, Chengdu, China

    8 shared publications
  • Qingting Liu

    Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu, China

    7 shared publications

Latest Publications

  • Open Access

    Molecular basis of PADI6 species-specific oligomerization in maternal regulatory complexes

    by Jinhong Li, Jialu Li, Pengliang Chi, Yiren Zeng, Sibei Liu, Sicheng Ju, Jingrui Huang, Qingting Liu, Zihan Zhang, Zhuo Han, et al.

    Peptidyl arginine deiminase 6 (PADI6) is an essential maternal effector in mammalian oocytes and preimplantation embryos. Recently, we identified the conserved maternal PADI6-UHRF1-UBE2D complex (MPU). MPU, together with the subcortical maternal complex (SCMC), further forms the cytoplasmic lattices (CPLs). Here, we reconstitute the mouse MPU (mMPU) and uncover striking species-specific differences in PADI6 oligomerization. In solution, mouse PADI6 (mPADI6) undergoes further oligomerization, forming tetramers, higher-order oligomers, and filamentous assemblies. Cryo-EM analysis reveals that the N-terminal IgG domain of mPADI6 mediates this behavior. These distinct oligomerization properties alter the stoichiometric ratios of the three components during assembly of both human MPU and mMPU. Moreover, PADI6 from different species adopts distinct oligomeric states in solution, suggesting potential differences in CPL assembly mechanisms. Together, our findings define the differential oligomerization capacity of PADI6 at the molecular level and provide a critical framework for understanding PADI6-mediated maternal regulatory assemblies during early embryonic development in different species.

  • Open Access

    Structural and mechanistic insights into the inhibition of Plasmodium falciparum MDR1

    by Ziyan Zhao, Jialu Li, Xinye Wang, Xiaofeng Liu, Nan Wang, Hanwen Xu, Cantao Quan, Yu Gao, Jing Zhang, Xiang Wang, et al.

    Malaria, caused by the parasite Plasmodium falciparum, remains a significant global health threat, with multidrug resistance posing a major challenge to treatment. The P-glycoprotein homolog P. falciparum Multidrug Resistance Protein 1 (PfMDR1) is a key determinant of resistance to first-line antimalarials like mefloquine (MFQ) and chloroquine. ACT-451840, a clinical phase I drug, has been developed as an antimalarial candidate, but its mechanism of action and interaction with drug resistance markers remain to be fully understood. Here, we present the cryo-electron microscopy structure of PfMDR1 in complex with ACT-451840, determined at a resolution of 3.42 Å. The structure reveals that ACT-451840 binds within the central cavity and locks PfMDR1 in an inward-open conformation, inhibiting its basal ATPase activity. A structural comparison of the ACT-451840-bound state with the previously reported MFQ-bound state provides a molecular explanation for how ACT-451840 resistance mutations can lead to the sensitization of MFQ. Furthermore, a comparative structural analysis and biochemical characterization with human ABCB1 reveal the selective mechanism of ACT-451840 against PfMDR1. Our findings provide a structural basis for the inhibitory mechanism of ACT-451840, which may inform the future development of antimalarial candidates targeting PfMDR1.

  • Open Access

    NLRP14 modulates the activity of E3 ubiquitin ligases during the oocyte-to-embryo transition

    by Sibei Liu, Qianqian Qi, Pengliang Chi, Haizhan Jiao, Li Yan, Yuechao Lu, Rongrong Zhang, Jinhong Li, Sicheng Ju, Zhuo Han, et al.

    NLRP14 is an essential maternal factor for mammalian embryonic development. Maternal ablation of NLRP14 in mice impairs DNA demethylation and calcium homeostasis in zygotes, causing early embryonic arrest. However, the underlying biochemical events remain largely unknown. Here, we identified two binding partners (KDM2A and UHRF1) of NLRP14 and further solved structures of NLRP14-KDM2A-SKP1 and NLRP14-UHRF1. Structural analysis revealed that NLRP14 modulates the SKP1-CUL1-F-box (SCF) E3 ubiquitin ligase and the RING-type E3 ubiquitin ligase UHRF1 through two distinct mechanisms. Mechanistically, NLRP14 competitively inhibits KDM2A-mediated SCF assembly or allosterically inhibits the activity of UHRF1 by occupying the E2 ubiquitin-conjugating enzyme (UBE2D) binding site of the ubiquitin-like (UBL) domain. Deletion of NLRP14 in mice increases ubiquitination levels in oocytes during maturation and after fertilization. Collectively, our findings identify NLRP14 as a dual regulator that restrains E3 ubiquitin ligase-driven ubiquitination by limiting SCF complex assembly and attenuating UHRF1 activity. This regulatory role is required to prevent excessive protein ubiquitination and maintain proteostasis during the oocyte-to-embryo transition, thereby supporting early embryonic development. Our study uncovers maternal regulation of proteostasis in oocytes and suggests that dysregulating proteostasis is an important factor in the pathogenesis of reproductive disorders.


  • Structure of the mouse cytoplasmic lattice

    by Pengliang Chi, Xiang Wang, Jialu Li, Jingrui Huang, Sicheng Ju, Sibei Liu, Li Yan, Yuechao Lu, Zihan Zhang, Zhuo Han, et al.

    The fertilized egg relies almost entirely on maternal stores in the oocyte to ensure the successful initiation of development1. The cytoplasmic lattices (CPLs) in mammalian oocytes store maternal-expressed proteins and play an essential role in embryogenesis2,3. Impairing multiple CPL members leads to early embryonic arrest (EEA), resulting in infertility in mammals. However, the mechanism underlying the assembly and storage of CPLs remains largely unknown. Here, we report the cryo-EM structure of a native mouse CPL repeating unit (~ 4 MDa) at 3.74 Å resolution. This repeating unit exhibits a tripartite architecture comprising a framework, extended linkers, and a CPL core. The external framework is built from PADI6 decamers and the subcortical maternal complexes (SCMC). Two linkers formed by NLRP4F polymerize the frameworks into an extended filament. In CPL core, the epigenetic regulator UHRF1 is trapped by PADI6, UBE2D, and NLRP14 in a compact, autoinhibited conformation that prevents nuclear entry and ubiquitin ligase activity. Moreover, the CPL core stores GTP-bound α/β-tubulin heterodimers and inactive SCF E3-ubiquitin ligase components (FBXW-SKP1 complex) in a poised but restrained state. These features establish CPLs as a dynamic regulatory pool that enables rapid microtubule assembly and tightly controlled ubiquitination during the oocyte-to-embryo transition. Together, this semi-in-situ structure illuminates CPL assembly and storage-module organization, and establishes CPLs as specialized proteostasis organelles for maternal regulation in oocytes and early embryonic development.


  • The maternal PADI6–UHRF1–UBE2D complex regulates ubiquitination during oocyte maturation and embryogenesis

    by Jinhong Li, Yuechao Lu, Zhili Xia, Pengliang Chi, Qianqian Qi, Sibei Liu, Sicheng Ju, Jialu Li, Zihan Zhang, Zhuo Han, et al.

    Proteostasis in mammalian oocytes is vital for successful reproduction. The cytoplasmic lattices (CPLs) of oocytes store essential maternal proteins for early embryo development. Here we show that PADI6, a core component of CPLs, forms a conserved ternary complex that we term MPU for maternal PADI6-UHRF1-UBE2D. The MPU complex regulates protein ubiquitination during oocyte maturation and early embryogenesis. We determined the cryo-electron microscopy structure of MPU and show that 86% (25/29) of clinically identified PADI6 missense variants disrupt MPU assembly, revealing a potential molecular mechanism linking dysregulation of ubiquitination on oocytes to abnormal embryonic development. Mechanistically, PADI6, with the assistance of UHRF1, sequesters UBE2D to prevent ubiquitin transfer from E2 to relevant substrate proteins, thereby suppressing the ubiquitination cascade. Therefore, our findings implicate PADI6 in the regulation of proteostasis by controlling the ubiquitination cascade, expanding our understanding of PADI6-dependent regulation of oocyte maturation and early embryogenesis.


  • Open Access

    Structural-guided identification of two modulators of β−1,3-glucan synthase FKS1

    by Jialu Li, Jian Li, Angqi Zhu, Xinli Dai, Juxiu Liu, Huayi Liu, Zhili Xia, Yuefan Dong, Wenyu Qian, Lunzhi Dai, et al.

    FKS1 is a β−1,3-glucan synthase critical for fungal cell wall formation and a target for antifungal drugs such as echinocandin and ibrexafungerp. However, the mechanisms regulating FKS1 activity remain largely unknown. Here, we reveal that transfer RNA (tRNA) acts as an endogenous inhibitor, whereas GSR1 functions as a stabilizer of FKS1. The cryo-EM structure of FKS1 adopts a tRNA-mediated homodimer configuration, representing a quiescent state of β−1,3-glucan synthase. Unexpectedly, the copurified endogenous tRNA is identified as a potent inhibitor that suppresses FKS1 activity. Moreover, high-resolution cryo-EM density analysis enable the identification of GSR1 as an additional binding partner of FKS1. Mutagenesis experiments confirm the interaction between FKS1 and GSR1. Evolutionarily conserved GSR1 is found to increase the stability of FKS1 in β−1,3-glucan biosynthesis. Collectively, our findings identify both tRNA and GSR1 as intrinsic modulators of β−1,3-glucan biosynthesis, thereby providing opportunities for the further development of FKS1-targeted antifungal drugs.


  • Open Access

    NLRP14 modulates the activity of E3 ubiquitin ligases during the oocyte-to-embryo transition

    by Dong Deng, Sibei Liu, Qianqian Qi, Pengliang Chi, Haizhan Jiao, Li Yan, Yuechao Lu, Rongrong Zhang, Jinhong Li, Sicheng Ju, et al.

    NLRP14 is an essential maternal factor for mammalian embryonic development. Maternal ablation of NLRP14 in mice impairs the DNA demethylation and calcium homeostasis of zygotes, leading to early embryonic arrest. However, the underlying biochemical events are still largely unknown. Here, we report that NLRP14 modulates the SKP1-CUL1-F-box (SCF) E3 ligase and the RING-type E3 ligase through two distinct mechanisms. Mechanistically, NLRP14 competitively inhibits the assembly of KDM2A-mediated SKP1-CUL1-F-box (SCF) E3 ligase and also allosterically inhibits the activity of UHRF1 via the competitive occupancy of the E2 ubiquitin ligase (UBE2) binding site of the ubiquitin-like (UBL) domain of UHRF1. Deletion of NLRP14 in mice resulted in increased protein ubiquitination levels in oocytes both during maturation and after fertilization. Along with increased proteasome levels during the oocyte-to-embryo transition, the Nlrp14 null oocytes exhibited an imbalance in protein homeostasis, leading to developmental arrest. Our study reveals the novel role of NLRP14 in regulating the ubiquitylation activity of E3 ligases, thereby establishing a theoretical framework for further investigation into maternal regulation of proteostasis and the pathogenesis of associated reproductive disorders.

  • Top Cited Papers
    Open Access

    Cryo-EM structure of the β-1,3-glucan synthase FKS1-Rho1 complex

    by Jialu Li, Huayi Liu, Jian Li, Juxiu Liu, Xinli Dai, Angqi Zhu, Qingjie Xiao, Wenyu Qian, Honghao Li, Li Guo, et al.

    β-1,3 Glucan synthase (GS) is essential for fungal cell wall biosynthesis. The GS holoenzyme comprises the glycosyltransferase FKS1 and its regulatory factor Rho1, a small GTPase. However, the mechanism by which Rho1 activates FKS1 in a GTP-dependent manner remains unclear. Here, we present two cryo-EM structures of FKS1, apo and in complex with Rho1. FKS1 adopts a cellulose synthase-like conformation. The interaction between Rho1 and FKS1 is enhanced in the presence of GTPγS. Rho1 is positioned within a pocket between the glycosyltransferase domain of FKS1 (GT domain) and the transmembrane helix spanning TM7-15. Comparison of the two structures reveals extensive conformational changes within FKS1. These alterations suggest that Rho1’s GTP/GDP cycling may act as a molecular pump, promoting a dynamic transition between the resting and active states of FKS1. Notably, Rho1 triggers FKS1 conformational changes that may push the growing glucan chain into FKS1’s transmembrane channel, thereby facilitating β-1,3-glucan elongation.


  • Open Access

    Structural insights into the inhibition mechanism of fungal GWT1 by manogepix

    by Xinli Dai, Xuanzhong Liu, Jialu Li, Hui Chen, Chuangye Yan, Yaozong Li, Hanmin Liu, Dong Deng, Xiang Wang

    Glycosylphosphatidylinositol (GPI) acyltransferase is crucial for the synthesis of GPI-anchored proteins. Targeting the fungal glycosylphosphatidylinositol acyltransferase GWT1 by manogepix is a promising antifungal strategy. However, the inhibitory mechanism of manogepix remains unclear. Here, we present cryo-EM structures of yeast GWT1 bound to the substrate (palmitoyl-CoA) and inhibitor (manogepix) at 3.3 Å and 3.5 Å, respectively. GWT1 adopts a unique fold with 13 transmembrane (TM) helixes. The palmitoyl-CoA inserts into the chamber among TM4, 5, 6, 7, and 12. The crucial residues (D145 and K155) located on the loop between TM4 and TM5 potentially bind to the GPI precursor, contributing to substrate recognition and catalysis, respectively. The antifungal drug, manogepix, occupies the hydrophobic cavity of the palmitoyl-CoA binding site, suggesting a competitive inhibitory mechanism. Structural analysis of resistance mutations elucidates the drug specificity and selectivity. These findings pave the way for the development of potent and selective antifungal drugs targeting GWT1.


  • Open Access

    The subcortical maternal complex modulates the cell cycle during early mammalian embryogenesis via 14-3-3

    by Zhuo Han, Rui Wang, Pengliang Chi, Zihan Zhang, Ling Min, Haizhan Jiao, Guojin Ou, Dan Zhou, Dandan Qin, Chengpeng Xu, et al.

    The subcortical maternal complex (SCMC) is essential for safeguarding female fertility in mammals. Assembled in oocytes, the SCMC maintains the cleavage of early embryos, but the underlying mechanism remains unclear. Here, we report that 14-3-3, a multifunctional protein, is a component of the SCMC. By resolving the structure of the 14-3-3-containing SCMC, we discover that phosphorylation of TLE6 contributes to the recruitment of 14-3-3. Mechanistically, during maternal-to-embryo transition, the SCMC stabilizes 14-3-3 protein and contributes to the proper control of CDC25B, thus ensuring the activation of the maturation-promoting factor and mitotic entry in mouse zygotes. Notably, the SCMC establishes a conserved molecular link with 14-3-3 and CDC25B in human oocytes/embryos. This study discloses the molecular mechanism through which the SCMC regulates the cell cycle in early embryos and elucidates the function of the SCMC in mammalian early embryogenesis.